{"abstract": "The Bristol-Myers Squibb Company, a drug maker, named its chief executive, James M. Cornelius, as board chairman, succeeding James D. Robinson III.", "web_url": "https://www.nytimes.com/2008/02/13/business/13bristol.html", "snippet": "The Bristol-Myers Squibb Company, a drug maker, named its chief executive, James M. Cornelius, as board chairman, succeeding James D. Robinson III.", "lead_paragraph": "The Bristol-Myers Squibb Company, a drug maker, named its chief executive, James M. Cornelius, as board chairman, succeeding James D. Robinson III, who resigned as nonexecutive chairman.", "print_section": "C", "print_page": "6", "source": "The New York Times", "multimedia": [], "headline": {"main": "New Chairman at Drug Maker", "kicker": null, "content_kicker": null, "print_headline": "New Chairman At Drug Maker", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Suspensions, Dismissals and Resignations", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Bristol-Myers Squibb Co", "rank": 3, "major": "N"}, {"name": "subject", "value": "Retirement", "rank": 4, "major": "N"}, {"name": "subject", "value": "Appointments and Executive Changes", "rank": 5, "major": "N"}], "pub_date": "2008-02-13T05:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Bloomberg News", "person": [{"firstname": "Bloomberg", "middlename": null, "lastname": "News", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/6583c5bb-a99f-5689-9c61-99f77c0684a7", "word_count": 134, "uri": "nyt://article/6583c5bb-a99f-5689-9c61-99f77c0684a7"}